India’s Global Health Blueprint
In the intricate web of efforts against AMR, India stands as a crucial front line, where diverse strategies are deployed to confront this unseen threat. With AMR casting a long shadow over public health, India’s approach exemplifies a dynamic confluence of global insights and localized action plans.
Central to this fight is the National Action Plan to combat AMR (NAP-AMR), India’s strategic blueprint, which spearheads antimicrobial stewardship across healthcare sectors. Despite its ambitious scope, the journey is punctuated with challenges – from implementing strategies to bridging research gaps. The key lies in transcending siloed efforts, fostering a unified front across single organizations and the broader healthcare landscape.
The World Health Organization (WHO)’s role in India underscores the global-local nexus in tackling AMR. Tailoring the ‘One Health Action’ programme to India’s distinct landscape, it manoeuvres through the complexities of state-level execution, revealing avenues for upcoming initiatives.
Further complicating this landscape is the Indian Council of Medical Research (ICMR) study, revealing a relentless upsurge in drug-resistant pathogens. The findings underscore the urgency for innovative solutions and responsive healthcare strategies.
A pivotal factor in this complex equation is the usage of antimicrobials in animal agriculture. Global trends foreshadow a substantial rise in antimicrobial consumption by 2030, prompting a call for improved antibiotic use and strategic interventions. In India, regulatory measures for antibiotic use in livestock, notably for growth promoters like colistin, are critical to curbing AMR’s march.
Exploring the terrain of smallholder dairy systems reveals crucial insights into animal health and drug practices, pivotal for tailoring AMR interventions. The Theory of Change approach, coupled with a review of ongoing strategies, illuminates the path for impactful actions against AMR.
Dr. Jagan Mohan Somagoni
